Effects of SGLT2-i & GLP1-RA on CV and Limb Events, Primarily in Patients with PAD | Nedaa Skeik, MD
Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists on Cardiovascular and Limb Events, Primarily in Patients with Peripheral Artery Disease
Presentation Date
Presentation Flyer
Document
Presentation Video
Presenters
Nedaa Skeik, MD, FACC, FACP, FSVM
Section Head, Vascular Medicine
Medical Director, Anticoagulation Clinic
Medical Director, Vein Center
Medical Director, Vascular Laboratories
Allina Health Minneapolis Heart Institute
